Ruxolitinib for the Treatment of Essential Thrombocythemia

Deregulated Janus Kinase 2 (JAK2) activation is central to the pathogenesis of most myeloproliferative neoplasms (MPNs), of which essential thrombocythemia (ET) is the most common entity. Patients with ET are risk-stratified according to their risk of thrombo-hemorrhagic complications. High-risk pat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Hemasphere
Main Authors: Gunawan, Arief, Harrington, Patrick, Garcia-Curto, Natalia, McLornan, Donal, Radia, Deepti, Harrison, Claire
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2018
Fag:
Review Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6746005/
https://ncbi.nlm.nih.gov/pubmed/31723782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000056
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker